QLT Asks FDA To Remove Blood Screening Requirement For Acne Treatment Aczone
Firm hopes results of Phase IV study convince FDA to approve a more marketable label for the topical acne treatment.
Firm hopes results of Phase IV study convince FDA to approve a more marketable label for the topical acne treatment.